USCOM (ASX:UCM) ROE % Adjusted to Book Value : -18.60% (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is USCOM ROE % Adjusted to Book Value?

USCOM's ROE % for the quarter that ended in Dec. 2023 was -69.37%. USCOM's PB Ratio for the quarter that ended in Dec. 2023 was 3.73. USCOM's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -18.60%.

USCOM ROE % Adjusted to Book Value Historical Data

The historical data trend for USCOM's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

USCOM ROE % Adjusted to Book Value Chart

USCOM Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-6.02

-4.16

-3.59

-20.17

-20.04

USCOM Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-11.45	-15.06	-26.78	-21.60	-18.60

Competitive Comparison of USCOM's ROE % Adjusted to Book Value

For the Medical Devices subindustry, USCOM's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

USCOM's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, USCOM's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where USCOM's ROE % Adjusted to Book Value falls into.

USCOM ROE % Adjusted to Book Value Calculation

USCOM's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-57.71%	/	2.88
	=	-20.04%

USCOM's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-69.37%	/	3.73
	=	-18.60%

USCOM ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of USCOM's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

USCOM (ASX:UCM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » USCOM Ltd (ASX:UCM) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Level 8, 66 Clarence Street, Suite 2, Sydney, NSW, AUS, 2000

Website

https://www.uscom.com.au

USCOM Ltd is engaged in the development, design, manufacture, and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The company's geographical segment includes Australia, Asia, America, Europe, and Other regions. It generates maximum revenue from Australia. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, SPIROSONIC, a pulmonary function testing device based on multi-path ultrasound technology and the VENTITEST and VENTITEST-S ultrasonic ventilator calibration devices for optimizing respiratory device performance.

USCOM (ASX:UCM) Headlines

No Headlines